As the global economy recovers in 2021 and the supply of the industrial chain improves, the Injection Flu Shot market will undergo major changes. According to the latest research, the market size of the Injection Flu Shot industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Injection Flu Shot industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Injection Flu Shot market during the next few years. The global Injection Flu Shot market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
This report presents a comprehensive overview, market shares, and growth opportunities of Injection Flu Shot market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
6 Months to 3 Years
> 3 Years
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
Table of Content
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Injection Flu Shot Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Injection Flu Shot by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Injection Flu Shot by Country/Region, 2017, 2022 & 2028
2.2 Injection Flu Shot Segment by Type
2.2.1 Trivalent Influenza Vaccine
2.2.2 Quadrivalent Influenza Vaccine
2.3 Injection Flu Shot Sales by Type
2.3.1 Global Injection Flu Shot Sales Market Share by Type (2017-2022)
2.3.2 Global Injection Flu Shot Revenue and Market Share by Type (2017-2022)
2.3.3 Global Injection Flu Shot Sale Price by Type (2017-2022)
2.4 Injection Flu Shot Segment by Application
2.4.1 6 Months to 3 Years
2.4.2 > 3 Years
2.5 Injection Flu Shot Sales by Application
2.5.1 Global Injection Flu Shot Sale Market Share by Application (2017-2022)
2.5.2 Global Injection Flu Shot Revenue and Market Share by Application (2017-2022)
2.5.3 Global Injection Flu Shot Sale Price by Application (2017-2022)
3 Global Injection Flu Shot by Company
3.1 Global Injection Flu Shot Breakdown Data by Company
3.1.1 Global Injection Flu Shot Annual Sales by Company (2020-2022)
3.1.2 Global Injection Flu Shot Sales Market Share by Company (2020-2022)
3.2 Global Injection Flu Shot Annual Revenue by Company (2020-2022)
3.2.1 Global Injection Flu Shot Revenue by Company (2020-2022)
3.2.2 Global Injection Flu Shot Revenue Market Share by Company (2020-2022)
3.3 Global Injection Flu Shot Sale Price by Company
3.4 Key Manufacturers Injection Flu Shot Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Injection Flu Shot Product Location Distribution
3.4.2 Players Injection Flu Shot Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Injection Flu Shot by Geographic Region
4.1 World Historic Injection Flu Shot Market Size by Geographic Region (2017-2022)
4.1.1 Global Injection Flu Shot Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Injection Flu Shot Annual Revenue by Geographic Region
4.2 World Historic Injection Flu Shot Market Size by Country/Region (2017-2022)
4.2.1 Global Injection Flu Shot Annual Sales by Country/Region (2017-2022)
4.2.2 Global Injection Flu Shot Annual Revenue by Country/Region
4.3 Americas Injection Flu Shot Sales Growth
4.4 APAC Injection Flu Shot Sales Growth
4.5 Europe Injection Flu Shot Sales Growth
4.6 Middle East & Africa Injection Flu Shot Sales Growth
5 Americas
5.1 Americas Injection Flu Shot Sales by Country
5.1.1 Americas Injection Flu Shot Sales by Country (2017-2022)
5.1.2 Americas Injection Flu Shot Revenue by Country (2017-2022)
5.2 Americas Injection Flu Shot Sales by Type
5.3 Americas Injection Flu Shot Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Injection Flu Shot Sales by Region
6.1.1 APAC Injection Flu Shot Sales by Region (2017-2022)
6.1.2 APAC Injection Flu Shot Revenue by Region (2017-2022)
6.2 APAC Injection Flu Shot Sales by Type
6.3 APAC Injection Flu Shot Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Injection Flu Shot by Country
7.1.1 Europe Injection Flu Shot Sales by Country (2017-2022)
7.1.2 Europe Injection Flu Shot Revenue by Country (2017-2022)
7.2 Europe Injection Flu Shot Sales by Type
7.3 Europe Injection Flu Shot Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Injection Flu Shot by Country
8.1.1 Middle East & Africa Injection Flu Shot Sales by Country (2017-2022)
8.1.2 Middle East & Africa Injection Flu Shot Revenue by Country (2017-2022)
8.2 Middle East & Africa Injection Flu Shot Sales by Type
8.3 Middle East & Africa Injection Flu Shot Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Injection Flu Shot
10.3 Manufacturing Process Analysis of Injection Flu Shot
10.4 Industry Chain Structure of Injection Flu Shot
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Injection Flu Shot Distributors
11.3 Injection Flu Shot Customer
12 World Forecast Review for Injection Flu Shot by Geographic Region
12.1 Global Injection Flu Shot Market Size Forecast by Region
12.1.1 Global Injection Flu Shot Forecast by Region (2023-2028)
12.1.2 Global Injection Flu Shot Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Injection Flu Shot Forecast by Type
12.7 Global Injection Flu Shot Forecast by Application
13 Key Players Analysis
13.1 Sanofi
13.1.1 Sanofi Company Information
13.1.2 Sanofi Injection Flu Shot Product Offered
13.1.3 Sanofi Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Sanofi Main Business Overview
13.1.5 Sanofi Latest Developments
13.2 CSL
13.2.1 CSL Company Information
13.2.2 CSL Injection Flu Shot Product Offered
13.2.3 CSL Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 CSL Main Business Overview
13.2.5 CSL Latest Developments
13.3 GSK
13.3.1 GSK Company Information
13.3.2 GSK Injection Flu Shot Product Offered
13.3.3 GSK Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 GSK Main Business Overview
13.3.5 GSK Latest Developments
13.4 Viatris
13.4.1 Viatris Company Information
13.4.2 Viatris Injection Flu Shot Product Offered
13.4.3 Viatris Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Viatris Main Business Overview
13.4.5 Viatris Latest Developments
13.5 AstraZeneca
13.5.1 AstraZeneca Company Information
13.5.2 AstraZeneca Injection Flu Shot Product Offered
13.5.3 AstraZeneca Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 AstraZeneca Main Business Overview
13.5.5 AstraZeneca Latest Developments
13.6 Hualan Bio
13.6.1 Hualan Bio Company Information
13.6.2 Hualan Bio Injection Flu Shot Product Offered
13.6.3 Hualan Bio Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Hualan Bio Main Business Overview
13.6.5 Hualan Bio Latest Developments
13.7 Changchun Institute of Biological
13.7.1 Changchun Institute of Biological Company Information
13.7.2 Changchun Institute of Biological Injection Flu Shot Product Offered
13.7.3 Changchun Institute of Biological Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Changchun Institute of Biological Main Business Overview
13.7.5 Changchun Institute of Biological Latest Developments
13.8 Sinovac
13.8.1 Sinovac Company Information
13.8.2 Sinovac Injection Flu Shot Product Offered
13.8.3 Sinovac Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Sinovac Main Business Overview
13.8.5 Sinovac Latest Developments
13.9 Jiangsu GDK
13.9.1 Jiangsu GDK Company Information
13.9.2 Jiangsu GDK Injection Flu Shot Product Offered
13.9.3 Jiangsu GDK Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Jiangsu GDK Main Business Overview
13.9.5 Jiangsu GDK Latest Developments
13.10 KM Biologics
13.10.1 KM Biologics Company Information
13.10.2 KM Biologics Injection Flu Shot Product Offered
13.10.3 KM Biologics Injection Flu Shot Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 KM Biologics Main Business Overview
13.10.5 KM Biologics Latest Developments
14 Research Findings and Conclusion
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
Jiangsu GDK
KM Biologics
*If Applicable.